Pasadena Private Wealth »

Oncternal Therapeutics shares owned by Pasadena Private Wealth

Quarter-by-quarter ownership of Oncternal Therapeutics (ONCT) shares owned by Pasadena Private Wealth from 13F filings

Historical chart of Pasadena Private Wealth investment in Oncternal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oncternal Therapeutics held by Pasadena Private Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncternal Therapeutics by Pasadena Private Wealth

Quarter filed Position value Share count Share price at filing
2024-06-30 $190k 25k 7.60

More positions owned by Pasadena Private Wealth

Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Schwab Strategic Tr Fundamental Us S (FNDA)
Vanguard Index Fds Sml Cp Grw Etf (VBK)
Schwab Strategic Tr Fundamental Us L (FNDX)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Flexshares Tr Mornstar Upstr (GUNR)
Amplify Etf Tr Cwp Enhanced Div (DIVO)
Direxion Shs Etf Tr Auspce Cmd Stg (COM)
Abrdn Etfs Bbrg All Comd K1 (BCI)
Apple (AAPL)
Grayscale Bitcoin Tr Btc Shs Rep Com Ut (GBTC)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)

View all positions for Pasadena Private Wealth

Top funds holding Oncternal Therapeutics

Vanguard Group
Millennium Management
BlackRock
Quantum Private Wealth
Dimensional Fund Advisors
Geode Capital Management
Pasadena Private Wealth
Richmond Brothers
Renaissance Technologies
Brighton Jones
Susquehanna International
Morgan Stanley
ADAR1 Capital Management
Acadian Asset Management
Jpmorgan Chase & Co

View all funds holding Oncternal Therapeutics